Implications for Creutzfeldt-Jakob Disease (CJD) in Dentistry: a Review of Current Knowledge

This review explores our current understanding of the risks of (variant) Creutzfeldt-Jakob disease transmission via dental practice, and whether they merit the rigorous enforcement of improved standards of instrument cleaning and decontamination. The recognition of prions as novel infectious agents in humans has caused significant concern among the public and medical professionals alike. Creutzfeldt-Jakob disease (CJD) in humans has been shown to be transmissible via several routes, including transplantation, contaminated medical products, and via neurosurgery. While the likelihood of transmission via dentistry is undoubtedly very low, this may be amplified considerably by unknown risk factors, such as disease prevalence (particularly in the UK), altered tissue distribution of vCJD, and the failure of decontamination processes to address the inactivation of prions adequately. Since current diagnostic techniques are unable to detect PrPSc in human dental tissues, there is limited evidence for the presence of infectivity. Given these uncertainties, the control of risk by reinforced and improved decontamination practices seems the most appropriate response.

[1]  A. Valleron,et al.  Risk Assessment of Transmission of Sporadic Creutzfeldt-Jakob Disease in Endodontic Practice in Absence of Adequate Prion Inactivation , 2007, PloS one.

[2]  P. Lantos,et al.  Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman. , 2007, Archives of neurology.

[3]  G. Mcdonnell,et al.  Prion inactivation using a new gaseous hydrogen peroxide sterilisation process. , 2007, The Journal of hospital infection.

[4]  P. Marsh,et al.  Cleanability of dental instruments – implications of residual protein and risks from Creutzfeldt-Jakob disease , 2007, BDJ.

[5]  G. Mcdonnell,et al.  Investigations of a prion infectivity assay to evaluate methods of decontamination. , 2007, Journal of microbiological methods.

[6]  M. D. Di Bari,et al.  PrPSc in Salivary Glands of Scrapie-Affected Sheep , 2007, Journal of Virology.

[7]  A. Kincaid,et al.  The Nasal Cavity Is a Route for Prion Infection in Hamsters , 2007, Journal of Virology.

[8]  M. Mcbride,et al.  IMPORTANT: ADVICE FOR DENTISTS ON RE-USE OF ENDODONTIC INSTRUMENTS AND VARIANT CREUTZFELDT-JAKOB DISEASE (vCJD) , 2007 .

[9]  Suvankar Pal,et al.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report , 2006, The Lancet.

[10]  Robert J Warren,et al.  Infectious Prions in the Saliva and Blood of Deer with Chronic Wasting Disease , 2006, Science.

[11]  J. T. Walker,et al.  Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  John Collinge,et al.  Kuru in the 21st century—an acquired human prion disease with very long incubation periods , 2006, The Lancet.

[13]  R. Bessen,et al.  Prion Infection of Oral and Nasal Mucosa , 2006, Journal of Virology.

[14]  James W Ironside,et al.  Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study , 2006, BMJ : British Medical Journal.

[15]  S. Prusiner,et al.  Inactivation of Prions by Acidic Sodium Dodecyl Sulfate , 2006, Journal of Virology.

[16]  J. Ironside,et al.  Predicting susceptibility and incubation time of human-to-human transmission of vCJD , 2005, The Lancet Neurology.

[17]  J Mackenzie,et al.  Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. , 2006, Vox sanguinis.

[18]  Mrc Prion.  Kuru in the 21st century-an acquired human prion disease with very long incubation periods , 2006 .

[19]  C. Herzog,et al.  PrPTSE Distribution in a Primate Model of Variant, Sporadic, and Iatrogenic Creutzfeldt-Jakob Disease , 2005, Journal of Virology.

[20]  D. Perrett,et al.  Residual protein levels on reprocessed dental instruments. , 2005, The Journal of hospital infection.

[21]  A. Kincaid,et al.  Extraneural Prion Neuroinvasion without Lymphoreticular System Infection , 2005, Journal of Virology.

[22]  J. Collinge,et al.  High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease , 2005, Gut.

[23]  A. Simpson,et al.  Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. , 2005, The Journal of general virology.

[24]  F. Scaravilli,et al.  Accumulation of Prion Protein in the Peripheral Nervous System in Human Prion Diseases , 2005, Journal of neuropathology and experimental neurology.

[25]  E. Bozzetta,et al.  Pathological Prion Protein in the Tongues of Sheep Infected with Naturally Occurring Scrapie , 2005, Journal of Virology.

[26]  Paul Clarke,et al.  Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility , 2005, Journal of The Royal Society Interface.

[27]  J. Collinge,et al.  An enzyme-detergent method for effective prion decontamination of surgical steel. , 2005, The Journal of general virology.

[28]  U. Rosenberg.  Effective cleaning processes and "efficacy against prions" , 2005 .

[29]  J. Collinge,et al.  Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype , 2004, Science.

[30]  G. Pauli,et al.  Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. , 2004, The Journal of general virology.

[31]  Mark Head,et al.  Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004 .

[32]  B. Mollenhauer,et al.  Sporadic Creutzfeldt-Jakob disease , 2004, Neurology.

[33]  P. Brown,et al.  Novel methods for disinfection of prion-contaminated medical devices , 2004, The Lancet.

[34]  M. Head,et al.  Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient , 2004, The Lancet.

[35]  A. Kincaid,et al.  Prion Infection of Skeletal Muscle Cells and Papillae in the Tongue , 2004, Journal of Virology.

[36]  Mark Penney,et al.  Prevalence of lymphoreticular prion protein accumulation in UK tissue samples , 2004, The Journal of pathology.

[37]  David M. Taylor,et al.  Proteolytic inactivation of the bovine spongiform encephalopathy agent. , 2004, Biochemical and biophysical research communications.

[38]  M. Mielke,et al.  Activity of an alkaline 'cleaner' in the inactivation of the scrapie agent. , 2004, The Journal of hospital infection.

[39]  K. Roth,et al.  Infectivity of Prion Protein Bound to Stainless Steel Wires: A Model for Testing Decontamination Procedures for Transmissible Spongiform Encephalopathies , 2004, Infection Control & Hospital Epidemiology.

[40]  L. Sehulster.  Prion Inactivation and Medical Instrument Reprocessing: Challenges Facing Healthcare Facilities , 2004, Infection Control & Hospital Epidemiology.

[41]  D. Dormont,et al.  Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection , 2004, The Lancet.

[42]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[43]  W. Nailon,et al.  Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. , 2004, The American journal of pathology.

[44]  J. Aiken,et al.  Delay in onset of prion disease for the HY strain of transmissible mink encephalopathy as a result of prior peripheral inoculation with the replication-deficient DY strain. , 2004, The Journal of general virology.

[45]  S. Porter.  Prion disease: possible implications for oral health care. , 2003, Journal of the American Dental Association.

[46]  C. Scully,et al.  Prions and the Oral Cavity , 2003, Journal of dental research.

[47]  J. Ironside,et al.  Investigation of PrPres in dental tissues in variant CJD , 2003, British Dental Journal.

[48]  C. Scully,et al.  Prions and the human transmissible spongiform encephalopathies. , 2003, Dental clinics of North America.

[49]  K. Oakley.  Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. Guidance from the UK Advisory Committee on Dangerous Pathogens and the Spongiform Encephalopathy Advisory Committee , 2003 .

[50]  R. Will.  Acquired prion disease: iatrogenic CJD, variant CJD, kuru. , 2003, British medical bulletin.

[51]  C. Lasmézas.  Putative functions of PrPC , 2003 .

[52]  B. Chesebro.  Introduction to the transmissible spongiform encephalopathies or prion diseases. , 2003, British medical bulletin.

[53]  M. Beekes,et al.  Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie , 2003, EMBO reports.

[54]  A. Kincaid,et al.  Rapid Prion Neuroinvasion following Tongue Infection , 2003, Journal of Virology.

[55]  C. Lasmézas.  Putative functions of PrP(C). , 2003, British medical bulletin.

[56]  K. Andolsek,et al.  Risk assessment , 2003, Nature.

[57]  J. Ironside,et al.  Pathological diagnosis of variant Creutzfeldt‐Jakob disease , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[58]  J. Ironside,et al.  The transmissible spongiform encephalopathies (prion diseases): a review for dental surgeons. , 2001, International dental journal.

[59]  C. Masters,et al.  Gerstmann–Sträussler–Scheinker syndrome,fatal familial insomnia, and kuru: a review ofthese less common human transmissiblespongiform encephalopathies , 2001, Journal of Clinical Neuroscience.

[60]  M. Moudjou,et al.  Cellular prion protein status in sheep: tissue-specific biochemical signatures. , 2001, The Journal of general virology.

[61]  J. Collinge,et al.  Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay , 2001, The Lancet.

[62]  L. McShane,et al.  Iatrogenic Creutzfeldt–Jakob disease at the millennium , 2000, Neurology.

[63]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[64]  R. Will,et al.  Laboratory diagnosis of variant Creutzfeldt–Jakob disease , 2000, Histopathology.

[65]  J. Hauw,et al.  Prion Protein is Not Detectable in Dental Pulp from Patients with Creutzfeldt-Jakob Disease , 2000, Journal of dental research.

[66]  M. Smits,et al.  Pathogenesis of natural scrapie in sheep. , 2000, Archives of virology. Supplementum.

[67]  R. Kordek.  The diagnosis of human prion diseases. , 2000, Folia neuropathologica.

[68]  R. Will.  The transmission of prions to humans , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[69]  F. Pisani,et al.  Transmission of the 263K scrapie strain by the dental route. , 1999, The Journal of general virology.

[70]  H. Budka,et al.  Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie , 1999, Acta Neuropathologica.

[71]  S. Itohara,et al.  Prions prevent neuronal cell-line death , 1999, Nature.

[72]  M. Enari,et al.  Infectivity of Scrapie Prions Bound to a Stainless Steel Surface , 1999, Molecular medicine.

[73]  C. Masters,et al.  Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study , 1999, The Lancet.

[74]  R. Will.  New variant Creutzfeldt-Jakob disease. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[75]  J Collinge,et al.  Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples , 1999, The Lancet.

[76]  M. Dawson,et al.  Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update , 1998, Veterinary Record.

[77]  S. Cousens,et al.  Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent , 1997, Nature.

[78]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[79]  S. Cousens,et al.  Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96 , 1997, BMJ.

[80]  S. L. Brown,et al.  Atmospheric and potable water exposures to methyl tert-butyl ether (MTBE). , 1997, Regulatory toxicology and pharmacology : RTP.

[81]  A. Hofman,et al.  A new variant of Creutzfeldt-Jakob disease in the UK , 1996, The Lancet.

[82]  David M. Taylor.  Exposure to, and Inactivation of, the Unconventional Agents that Cause Transmissible Degenerative Encephalopathies , 1996 .

[83]  J. Bell,et al.  A new variant of Creutzfeldt-Jakob disease: neuropathological and clinical features. , 1996, Cold Spring Harbor symposia on quantitative biology.

[84]  J. Mcdermott,et al.  Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. , 1995, Biochemical and biophysical research communications.

[85]  R. Moriuchi,et al.  Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice. , 1993, Journal of General Virology.

[86]  P. Lantos,et al.  Prion protein immunocytochemistry helps to establish the true incidence of prion diseases , 1992, Neuroscience Letters.

[87]  R. Will,et al.  Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study , 2006, BMJ.

[88]  Y. Itoyama,et al.  Clustering of three cases of Creutzfeldt‐Jakob disease near Fukuoka City, Japan , 1991, Acta neurologica Scandinavica.

[89]  T. Crow,et al.  Prion dementia without characteristic pathology , 1990, The Lancet.

[90]  T. Crow,et al.  DIAGNOSIS OF GERSTMANN-STRÄUSSLER SYNDROME IN FAMILIAL DEMENTIA WITH PRION PROTEIN GENE ANALYSIS , 1989, The Lancet.

[91]  J. Ryan,et al.  Bovine spongiform encephalopathy: epidemiological studies , 1988, Veterinary Record.

[92]  R. Will,et al.  Evidence for case-to-case transmission of Creutzfeldt-Jakob disease , 1982, Journal of neurology, neurosurgery, and psychiatry.

[93]  R. Carp.  TRANSMISSION OF SCRAPIE BY ORAL ROUTE EFFECT OF GINGIVAL SCARIFICATION , 1982, The Lancet.

[94]  Jonathan O. Harris,et al.  Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering , 1979, Annals of neurology.

[95]  P Brown,et al.  Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). , 1977, The New England journal of medicine.

[96]  D. Gajdusek,et al.  DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.

[97]  N. Da.  Letter: Hepatitis with hindsight. , 1974 .

[98]  A. Devoe,et al.  Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.

[99]  D. Gajdusek,et al.  Transmission of Two Subacute Spongiform Encephalopathies of Man (Kuru and Creutzfeldt–Jakob Disease) to New World Monkeys , 1971, Nature.

[100]  C. Eklund,et al.  Pathogenesis of scrapie virus infection in the mouse. , 1967, The Journal of infectious diseases.

[101]  G. C. Millson,et al.  Distribution of the scrapie agent in the tissues of experimentally inoculated goats. , 1962, Journal of comparative pathology.